GSK-111535

Study Sponsor: GSK

Study Title

Immunogenicity and reactogenicity study of GlaxoSmithKline Biologicals' Infanrix™/Hib vaccine administered as a booster dose to 18-24 months old children

Medicine or Vaccine (generic name)

Diphtheria, Tetanus, Acellular Pertussis Vaccine Adsorbed

Sponsor Identification Number

111535

Trial Registry Identification Number(#'s)

NCT00696423 2015-001507-31

Medical Condition

Acellular pertussis; Diphtheria; Tetanus

Phase

Phase 3

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=111535

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00696423

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2015-001507-31

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

May 2013